Cowen Prime Advisors’s Cytosorbents Corp CTSO Stock Holding History

Cowen Prime Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$152K	Sell	42,301 -3,749	-8%	-$11.9K	0.05%	96
2023 Q1	$113K	Buy	46,050 +4,850	+12%	+$14.6K	0.05%	100
2022 Q4	$64K	Sell	41,200 -1,000	-2%	-$1.48K	0.03%	119
2022 Q3	$57K	Hold	42,200	–	–	0.03%	104
2022 Q2	$92K	Buy	42,200 +26,600	+171%	+$61.1K	0.05%	96
2022 Q1	$50K	Buy	15,600 +11,850	+316%	+$42.4K	0.02%	123
2021 Q4	$16K	Buy	3,750 +2,550	+213%	+$14.3K	0.01%	145
2021 Q3	$10K	Buy	+1,200	New	+$9.75K	﹤0.01%	149
2020 Q3	–	Sell	-42,200	Closed	-$92K	–	182
2020 Q2	$92K	Buy	42,200 +41,200	+4,120%	+$378K	0.05%	96
2020 Q1	$8K	Buy	+1,000	New	+$5.05K	﹤0.01%	158

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Cowen Prime Advisors's CTSO Position: Q2 2023 in Review

Cowen Prime Advisors reduced its Cytosorbents Corp (CTSO) stake by 8.1% in Q2 2023, selling an estimated $11.9K and leaving 42,301 shares worth $152K. The position accounts for 0.05% of the portfolio, ranked #96.

Cowen Prime Advisors first reported a position in CTSO in Q1 2020 and has held it in 10 quarters since. 58 funds tracked by Wall St. Rank hold CTSO as of Q2 2023.

Cowen Prime Advisors held 42,301 shares of Cytosorbents Corp worth $152K as of Q2 2023.
Cowen Prime Advisors sold 3,749 Cytosorbents Corp shares in Q2 2023, an estimated $11.9K.
Cytosorbents Corp made up 0.05% of Cowen Prime Advisors's portfolio in Q2 2023, its #96 holding.
Cowen Prime Advisors first reported a position in Cytosorbents Corp in Q1 2020 and has held it in 10 quarters since.
58 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.